Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan-Feb;70(1):175-176.
doi: 10.1016/j.ihj.2017.05.009. Epub 2017 May 15.

Metformin in heart failure patients

Abdulhalim Jamal Kinsara  1 , Yasser Mansour Ismail  2
Affiliations
Review

Metformin in heart failure patients

Abdulhalim Jamal Kinsara et al. Indian Heart J. 2018 Jan-Feb.

Abstract

The use of metformin was considered a contraindication in heart failure patients because of the potential risk of lactic acidosis; however, more recent evidence has shown that this should no longer be the case. We reviewed the current literature and the recent guideline to correct the misconception.

Keywords: Heart failure; Metformin; Safety.

PubMed Disclaimer

References

    1. Choy C.K., Rodgers J.E., Nappi J.M., Haines S.T. Type 2 diabetes mellitus and heart failure. Pharmacotherapy. 2008;28(February (2)):170–192. - PubMed
    1. Cosmi F., Cosmi D. Metformin and insulin in chronic heart failure: contraindications not contraindicated and indications not indicated. G Ital Cardiol (Rome) 2011;12(December (12)):796–803. - PubMed
    1. Mudoni A., Caccetta F., Caroppo M. Lactic acidosis, acute renal failure and heart failure during treatment with metformin: what do we know? G Ital Nefrol. 2015;32(5) pii: gin/32.5.6. - PubMed
    1. Fácila L., Fabregat-Andrés Ó., Bertomeu V. Metformin and risk of long-term mortality following an admission for acute heart failure. J Cardiovasc Med (Hagerstown) 2017;18(February (2)):69–73. - PubMed
    1. Crowley M.J., Diamantidis C.J., McDuffie J.R. Clinical outcomes of metformin use in populations with chronic kidney disease, congestive heart failure, or chronic liver disease: a systematic review. Ann Intern Med. 2017;166(February (3)):191–200. - PMC - PubMed

MeSH terms